Medimix International
 | |
| Private | |
| Industry | Life Sciences |
| Founded | 1989 |
| Headquarters | Miami, Florida |
Key people | Henry Gazay, CEO |
| Products | SaaS |
| Website | medimix.net |
Medimix is a global technology company that specializes in the life science industries, headquartered in Miami, Florida. The company was founded in 1989 in France, and moved its global headquarters to the United States in 2002. Medimix International is one of the pioneers in online real world insights for the lifescience industries, and has developed a proprietary panel of health care professionals since 1995.
Medimix International is a member of the American Marketing Association (AMA), Pharmaceutical Business Intelligence Research Group (PBIRG), and participates to the work and conferences of the American Society of Clinical Oncology, ASCO European Society for Medical Oncology, ESMO, American Society of Hematology ASH and European Hematology Association EHA.
Business specialization
Medimix International specializes in the health care sector, working mainly for the pharmaceutical, biotech, and medical device industries. Medimix International offers Evidence based and Real World Insights solutions, derived from a proprietary internet platform. Medimix International introduced different breakthroughs in cloud based and evidence based research such as LiveTracker (Real Time and Real World tracking of specialty drugs usage). With LiveTracker Medimix has quickly become a significant player in Oncology and Hematology Real World Evidence tracking solutions.
Performance
Medimix International is a privately held company that experienced an organic CAGR of 53% through 2014-2018. In 2017, Medimix International derived 35% of its revenue from North America, 30% from Europe and 15% from Latin America. The Asia-Pacific region and the Middle East together accounted for 20% of revenues. In 2014 Medimix International launched LiveTracker, the first continuous prescription tracking in specialty pharmaceuticals. By mid 2018, LiveTracker is available in 50 countries and 12 Therapeutic areas in Oncology, Hematology and Diabetes.
Charity
In June 2018 Medimix International began a participative charity program whereby its panelist around the world can donate part of their survey related honoraria to the research for Cancer, with Medimix matching $ to $. The first charity donation are made to the Cancer Research Institute